Summary:
- The HPV (Human Papillomavirus) vaccine is a critical tool in preventing certain types of cancer, including cervical, anal, and throat cancers.
- A new clinical trial has found that a single dose of the HPV vaccine is just as effective in preventing HPV infection as the standard two-dose regimen.
- This is an important finding as a single-dose vaccine could make it easier for more people, especially in developing countries, to access and complete the HPV vaccination series, leading to better protection against HPV-related cancers.